SEC Form 4 · accession 0001354488-16-007960
Acer Therapeutics Inc. · ACER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott B Seaman
Director
Period of report
Jun 30, 2016
Accepted (ET)
Jul 1, 2016 · 9:02 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2016 | A | 6,455 | $0.00 | A | 23,534 | D | |
| Common StockF1 | holding | — | — | — | 129,676 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Held by Alkek and Williams Ventures, Ltd. (?Ventures?). Chaswil, Ltd. (?Chaswil?) is the investment manager of Ventures and holds voting power and investment power with respect to the Issuer securities held by Ventures. Mr. Seaman is a registered principal of Chaswil and has shared voting power and/or investment power with respect to the Issuer securities held by Ventures. Mr. Seaman disclaims beneficial ownership of the shares held by Ventures except to the extent of any pecuniary interest therein.